Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Giant Cell Tumor of Bone 2Breast Neoplasms 2Thyroid Cancer Metastatic 1Osteoporotic Fractures 1Osteoporosis 1Osteopetrosis, mild autosomal recessive form 1Osteopetrosis, Autosomal Recessive 7 1Osteoblastoma 1Neoplasm Metastasis 1Musculoskeletal Pain 1Melanoma 1Kidney Neoplasms 1Granuloma, Giant Cell 1Chondroblastoma 1Carcinoma, Renal Cell 1Bone Metastasis From Solid Tumors 1Bone Metastases From Solid Tumors 1Bone Metastases 1Bone Cysts, Aneurysmal 1Arthralgia 1

Interventions

Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Bone Metastasis From Solid Tumors × Denosumab × Clear all
NCT04494373 2020-08-04

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Phase 1 Unknown
154 enrolled
Other solid neoplasm

Bone Metastasis From Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡